Therefore, it could be suggested that COVID-19 patients with downregulated miR-146a expression are expected to have elevated levels of pro-inflammatory cytokines, specifically IL-6, and increased susceptibility to cytokine storms. This evidence concerns the gene IL6 and COVID-19.